Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction

Area of Science:

• Endocrinology
• Reproductive Medicine
• Women's Health

Background:

• Menstrual dysfunction and hyperandrogenism are common in women.
• Partial deficiencies in adrenocortical hydroxylase enzymes can cause these symptoms.

Purpose of the Study:

• To investigate the role of 11- or 21-hydroxylase deficiency in women with menstrual dysfunction and hyperandrogenism.
• To evaluate the efficacy of adrenocortical suppression therapy in managing these conditions.

Main Methods:

• Adrenocorticotropic hormone stimulation tests were performed on 48 women.
• Prednisone therapy was initiated for adrenocortical suppression.
• Some patients received additional clomiphene treatment.

Main Results:

• Late-onset 11- or 21-adrenocortical hydroxylase deficiency was identified.
• 83% of women showed improvement in menstrual regularity or conceived.
• Pregnancy rates were 64% overall and 93% corrected in women desiring fertility.

Conclusions:

• Partial 11- or 21-hydroxylase deficiency is a significant factor in women with hyperandrogenism and menstrual abnormalities.
• Adrenocortical suppression therapy with prednisone is indicated and effective.
• Treatment can lead to significant improvement in menstrual disturbances and fertility outcomes.